---
title: "Quoin Pharmaceuticals (QNRX) Receives a Buy from Maxim Group"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285751595.md"
description: "Maxim Group analyst Naz Rahman has reiterated a Buy rating on Quoin Pharmaceuticals (QNRX) with a price target of $40.00. Alliance Global Partners also maintains a Buy rating with a $35.00 target. Rahman focuses on the Healthcare sector and has an average return of -9.6% with a 35.83% success rate on his stock recommendations."
datetime: "2026-05-08T15:55:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285751595.md)
  - [en](https://longbridge.com/en/news/285751595.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285751595.md)
---

# Quoin Pharmaceuticals (QNRX) Receives a Buy from Maxim Group

Maxim Group analyst Naz Rahman reiterated a Buy rating on Quoin Pharmaceuticals yesterday and set a price target of $40.00.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Rahman covers the Healthcare sector, focusing on stocks such as Vertex Pharmaceuticals, Quoin Pharmaceuticals, and Silexion Therapeutics. According to TipRanks, Rahman has an average return of \-9.6% and a 35.83% success rate on recommended stocks.

In a report released today, Alliance Global Partners also reiterated a Buy rating on the stock with a $35.00 price target.

### Related Stocks

- [QNRX.US](https://longbridge.com/en/quote/QNRX.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [VRTX.US](https://longbridge.com/en/quote/VRTX.US.md)
- [SLXN.US](https://longbridge.com/en/quote/SLXN.US.md)
- [74907L409.US](https://longbridge.com/en/quote/74907L409.US.md)
- [SLXNW.US](https://longbridge.com/en/quote/SLXNW.US.md)

## Related News & Research

- [LifeSci Capital Sticks to Their Buy Rating for Tenax Therapeutics (TENX)](https://longbridge.com/en/news/286648286.md)
- [Roth MKM Sticks to Their Buy Rating for Capricor Therapeutics (CAPR)](https://longbridge.com/en/news/286497683.md)
- [Acrivon Therapeutics, Inc. (ACRV) Receives a Buy from Oppenheimer](https://longbridge.com/en/news/286428001.md)
- [Analyst Reiterates Buy on Corbus, Maintains $38 Price Target on CRB-701 Oncology Potential](https://longbridge.com/en/news/286284525.md)
- [AbbVie Inc. $ABBV Shares Purchased by RiverFront Investment Group LLC](https://longbridge.com/en/news/286750290.md)